Chaoliu Dai

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2020 · 833 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +13

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2023 · 452 citations · Full text

Medicine, Oncology, Cancer Control +12

Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial

Qian Chen, Chang Shu, Arian Laurence et al. · Gut · 2018 · 258 citations · Full text

Medicine, Oncology, Pharmacology +13

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

Juxian Sun, Xinyu Bi, Mengchao Wu et al. · Liver Cancer · 2022 · 110 citations · Full text

Medicine, Oncology, Pharmacotherapy +16